GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Non Operating Income

BCAX (Bicara Therapeutics) Non Operating Income : $-0.05 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Bicara Therapeutics's Non Operating Income for the three months ended in Sep. 2024 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.05 Mil.

Bicara Therapeutics Non Operating Income Historical Data

The historical data trend for Bicara Therapeutics's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics Non Operating Income Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23
Non Operating Income
-0.08 -13.41

Bicara Therapeutics Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Non Operating Income Get a 7-Day Free Trial - -13.33 -0.05 - -

Bicara Therapeutics Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bicara Therapeutics Non Operating Income Related Terms

Thank you for viewing the detailed overview of Bicara Therapeutics's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Bicara Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Non Operating Income
Comparable Companies
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Website
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.